ClearPoint Neuro, Inc. (CLPT)
NASDAQ: CLPT · Real-Time Price · USD
11.29
+0.03 (0.27%)
At close: Jul 2, 2025, 4:00 PM
11.39
+0.10 (0.89%)
After-hours: Jul 2, 2025, 7:00 PM EDT
ClearPoint Neuro Market Cap
ClearPoint Neuro has a market cap or net worth of $319.11 million as of July 2, 2025. Its market cap has increased by 103.52% in one year.
Market Cap
319.11M
Enterprise Value
310.16M
1-Year Change
103.52%
Ranking
Category
Stock Price
$11.29
Market Cap Chart
Since May 22, 2012, ClearPoint Neuro's market cap has increased from $30.30M to $319.11M, an increase of 953.17%. That is a compound annual growth rate of 19.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2025 | 315.20M | -25.71% |
| Dec 31, 2024 | 424.30M | 153.77% |
| Dec 29, 2023 | 167.20M | -19.62% |
| Dec 30, 2022 | 208.00M | -21.57% |
| Dec 31, 2021 | 265.20M | -1.08% |
| Dec 31, 2020 | 268.10M | 267.26% |
| Dec 31, 2019 | 73.00M | 337.13% |
| Dec 31, 2018 | 16.70M | -41.61% |
| Dec 29, 2017 | 28.60M | 132.52% |
| Dec 30, 2016 | 12.30M | -56.84% |
| Dec 31, 2015 | 28.50M | -41.84% |
| Dec 31, 2014 | 49.00M | -42.22% |
| Dec 31, 2013 | 84.80M | 10.42% |
| Dec 31, 2012 | 76.80M | 153.47% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 702.07B |
| Johnson & Johnson | 369.31B |
| AbbVie | 327.28B |
| Novo Nordisk | 307.21B |
| UnitedHealth Group | 284.91B |
| Novartis AG | 236.92B |
| Abbott Laboratories | 236.18B |
| AstraZeneca | 215.00B |